News

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

4 June 2024

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

Avance Clinical is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.

  • Reset
Introducing William Faria, the New Vice President of Biometrics at Avance Clinical

16 April 2024

Introducing William Faria, the New Vice President of Biometrics at Avance Clinical

Avance Clinical proudly welcomes William Faria as its new Vice President of Biometrics. With an extensive background in data management within the biometrics sector, William brings a wealth of experience and a global perspective to his new role.

Avance Clinical Appoints US-Based Executives – SVP Scientific And Regulatory Affairs, And Director Business Development

21 September 2023

Avance Clinical Appoints US-Based Executives – SVP Scientific And Regulatory Affairs, And Director Business Development

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, announces two key appointments in the US to support its continued global growth.

Avance Clinical Appoints North America SVP with Global Contract Research Organization, Data Quality and DCT Expertise

1 March 2023

Avance Clinical Appoints North America SVP with Global Contract Research Organization, Data Quality and DCT Expertise

Avance Clinical today announced the appointment of John Mann as Senior Vice President, North America Operations.

Proven industry
experience & expertise

500+

Studies in the past 5 years

330+

Experienced team members

18k+

Participants past 5 years

30

Years of CRO experience